SimplyRich’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.11M | Sell |
84,741
-1,506
| -2% | -$71.4K | 0.8% | 23 |
|
|
2025
Q4 | $4.39M | Buy |
86,247
+1,626
| +2% | +$83.1K | 1.15% | 15 |
|
|
2025
Q3 | $4.7M | Sell |
84,621
-7,782
| -8% | -$456K | 1.27% | 14 |
|
|
2025
Q2 | $6.38M | Buy |
92,403
+5,797
| +7% | +$394K | 1.78% | 10 |
|
|
2025
Q1 | $6.01M | Buy |
86,606
+527
| +0.6% | +$43.5K | 1.74% | 11 |
|
|
2024
Q4 | $7.4M | Sell |
86,079
-115
| -0.1% | -$12.4K | 2.11% | 10 |
|
|
2024
Q3 | $10.3M | Sell |
86,194
-330
| -0.4% | -$44K | 2.86% | 7 |
|
|
2024
Q2 | $12.3M | Sell |
86,524
-4
| -0% | -$530 | 3.91% | 6 |
|
|
2024
Q1 | $11.1M | Hold |
86,528
| – | – | 3.59% | 6 |
|
|
2023
Q4 | $8.95M | Hold |
86,528
| – | – | 3.08% | 7 |
|
|
2023
Q3 | $7.87M | Sell |
86,528
-12
| -0% | -$1.06K | 3.82% | 5 |
|
|
2023
Q2 | $7M | Buy |
86,540
+10
| +0% | +$817 | 2.5% | 10 |
|
|
2023
Q1 | $6.88M | Buy |
86,530
+1,402
| +2% | +$99.4K | 2.59% | 9 |
|
|
2022
Q4 | $5.76M | Sell |
85,128
-8
| -0% | -$469 | 2.29% | 9 |
|
|
2022
Q3 | $4.24M | Hold |
85,136
| – | – | 1.91% | 11 |
|
|
2022
Q2 | $4.74M | Sell |
85,136
-20
| -0% | -$1.11K | 1.97% | 10 |
|
|
2022
Q1 | $4.73M | Sell |
85,156
-76
| -0.1% | -$3.9K | 1.65% | 12 |
|
|
2021
Q4 | $4.77M | Sell |
85,232
-50
| -0.1% | -$2.71K | 1.58% | 13 |
|
|
2021
Q3 | $4.09M | Hold |
85,282
| – | – | 1.49% | 14 |
|
|
2021
Q2 | $3.57M | Buy |
85,282
+330
| +0.4% | +$12.8K | 1.64% | 12 |
|
|
2021
Q1 | $2.86M | Sell |
84,952
-66
| -0.1% | -$2.35K | 1.14% | 19 |
|
|
2020
Q4 | $2.97M | Sell |
85,018
-14
| -0% | -$484 | 1.33% | 17 |
|
|
2020
Q3 | $2.95M | Hold |
85,032
| – | – | 1.48% | 15 |
|
|
2020
Q2 | $2.79M | Sell |
85,032
-54
| -0.1% | -$1.72K | 1.53% | 13 |
|
|
2020
Q1 | $2.56M | Sell |
85,086
-1,050
| -1% | -$31.3K | 1.71% | 12 |
|
|
2019
Q4 | $2.49M | Sell |
86,136
-66
| -0.1% | -$1.83K | 1.25% | 18 |
|
|
2019
Q3 | $2.23M | Hold |
86,202
| – | – | 1.22% | 18 |
|
|
2019
Q2 | $2.2M | Hold |
86,202
| – | – | 1.22% | 19 |
|
|
2019
Q1 | $2.25M | Sell |
86,202
-106
| -0.1% | -$2.6K | 1.83% | 12 |
|
|
2018
Q4 | $1.98M | Sell |
86,308
-28
| -0% | -$622 | 1.82% | 13 |
|
|
2018
Q3 | $2.04M | Hold |
86,336
| – | – | 1.11% | 20 |
|
|
2018
Q2 | $1.99M | Sell |
86,336
-110
| -0.1% | -$2.61K | 1.14% | 19 |
|
|
2018
Q1 | $2.13M | Hold |
86,446
| – | – | 1.19% | 17 |
|
|
2017
Q4 | $2.32M | Buy |
+86,446
| New | +$2.2M | 1.3% | 15 |
|
Other funds holding NVO
DAM
F
SimplyRich's NVO Position: Q1 2026 in Review
SimplyRich reduced its Novo Nordisk (NVO) stake by 1.7% in Q1 2026, selling an estimated $71.4K and leaving 84,741 shares worth $3.11M. The position accounts for 0.8% of the portfolio, ranked #23.
SimplyRich first reported a position in NVO in Q4 2017 and has held it in 34 quarters since. The position peaked at $12.3M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- SimplyRich held 84,741 shares of Novo Nordisk worth $3.11M as of Q1 2026.
- SimplyRich sold 1,506 Novo Nordisk shares in Q1 2026, an estimated $71.4K.
- Novo Nordisk made up 0.8% of SimplyRich's portfolio in Q1 2026, its #23 holding.
- SimplyRich first reported a position in Novo Nordisk in Q4 2017 and has held it in 34 quarters since.
- SimplyRich's Novo Nordisk position peaked at $12.3M in Q2 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on SimplyRich's 13F filing for Q1 2026, filed 1 May 2026.